- ￥400 - 900
- MedChemExpress(MCE)
- 美国
- HY-B0284
- 2025年07月13日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
4°C, protect from light
- 英文名：
BAY-a-1040
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- CAS号：
21829-25-4
- 规格：
10 mM * 1 mL/500 mg/1 g/5 g/10 g
| 规格： | 10 mM * 1 mL | 产品价格： | ￥500.0 |
|---|---|---|---|
| 规格： | 500 mg | 产品价格： | ￥400.0 |
| 规格： | 1 g | 产品价格： | ￥500.0 |
| 规格： | 5 g | 产品价格： | ￥700.0 |
| 规格： | 10 g | 产品价格： | ￥900.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
Nifedipine
CAS No. : 21829-25-4
MCE 国际站：Nifedipine
产品活性：Nifedipine (BAY-a-1040) 是有效的钙离子通道 (calcium channel) 阻滞剂，常用于心肌功能不全的相关研究。
研究领域：Membrane Transporter/Ion Channel | Neuronal Signaling | Autophagy
作用靶点：Calcium Channel | Autophagy
In Vitro: Nifedipine (BAY-a-1040) (100 μM) significantly lowers the viability of the WKPT-0293 Cl.2 Cells, and treatment of nifedipine (10 or 100 μM) plus FAC induces a significant reduction in cell viability, but there are no significant differences in viability between the control cells and the cells treated with 100 μM of FAC or 1 and 10 μM of nifedipine.Nifedipine (BAY-a-1040) (1, 10, or 100 μM) significantly increases iron level in WKPT-0293 Cl.2 cells. Nifedipine treatment also increases expression of TfR1, DMT1+IRE and DMT1-IRE in WKPT-0293 Cl.2 cells. In addition, co-treatment with nifedipine (100 μM) and FAC (100 μM) increases TfR1, DMT1+IRE and DMT1-IRE expression in WKPT-0293 Cl.2 cells. Nifedipine plus ritodrine produces a significantly greater inhibition of contractility than each drug alone in the midrange of concentrations. The combination of nifedipine plus nitroglycerin or nifedipine plus atosiban produces a significantly greater inhibition than nitroglycerin or atosiban alone but not greater than nifedipine. The combination of nifedipine plus NS-1619 (Ca2+-activated K+ [BKCa] channel opener) reduces the inhibitory effect of each drug. Nifedipine (BAY-a-1040) (2 μM) significantly inhibits P. capsici mycelial growth and sporulation. Nifedipine (BAY-a-1040)-induced inhibition of mycelial growth is calcium-dependent. Nifedipine (0.5 μM) increases P. capsici sensitivity to H2O2 in a calcium-dependent manner.
In Vivo: In Nifedipine (BAY-a-1040) (50 mg/kg)- and CsA-treated rats, the BL dimensions (BLi and BLk), MD dimensions (MDk) and vertical dimensions (VHi and VHk) are significantly increased (P < 0.05) at the end of the 4th week.
相关产品：Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Membrane Transporter/Ion Channel Compound Library | Neuronal Signaling Compound Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | Autophagy Compound Library | Drug Repurposing Compound Library | Anti-Cardiovascular Disease Compound Library | NMPA-Approved Drug Library | Orally Active Compound Library | FDA Approved & Pharmacopeial Drug Library | Neuroprotective Compound Library | Drug-Induced Liver Injury (DILI) Compound Library | Rare Diseases Drug Library | Calcium Channel Blocker Library | FDA-Approved Anticancer Drug Library | Human Metabolite Library | Off-patent Drug Library | Antihypertensive Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Cell Death Library | Ion Channel Compound Library | Thapsigargin | Ionomycin | L-Ascorbic acid | Minocycline hydrochloride | Verapamil | 2-Aminoethyl diphenylborinate | Acetylcholine chloride | GSK1016790A | Fasudil Hydrochloride | Ebselen | Halofuginone | Tetrandrine | Carbamazepine | Ruthenium red | CDN1163 | ISX-9 | Gabapentin | TPC2-A1-N | Bay K 8644 | Ethacrynic acid | L-Phenylalanine | Istaroxime hydrochloride | Amlodipine | Digitoxin | Diltiazem hydrochloride | Cromolyn sodium | Mibefradil dihydrochloride
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Cell：颜宁团队最新研究！首次破解这两种药物联合使用引起致命副作用的结构基础
与其他 Cav 抑制剂互作的原因：Cav 抑制剂硝苯地平（nifedipine）与 MNI-1 的距离约 7Å，无法产生直接互作；另一种 Cav 抑制剂维拉帕米（verapamil）则因结合位置的重叠，会与 MNI-1 产生竞争。因此上述两种抑制剂均无法与 MNI-1 产生协同作用。 最后，研究者通过分子对接模拟其它丙肝病毒抑制剂（如 MK-3682）作用于 hCav1.3AS 的结合模式，并计算结合的自由能，评估了丙肝病毒抑制剂的疗效。发现相较于索非布韦，MK-3682 产生的结构差异和结合自由能均高于
性拮抗β-受体的作用，可防治心绞痛。雷诺病及偏头痛等。 【不良反应】较少，约2%～5%患者可能出现，注射给药可引起房室传导阻滞及低血压。其他副作用有皮疹、头痛、面部潮红等。 硝苯地平 硝苯地平（nifedipine），又名心痛定。 【药理作用】硝苯地平的作用与维拉帕米不同，它对窦房结房室结及心收缩性的抑制作用较弱，对血管的舒张作用明显。给药量略大反能加速房室传导，是交感神经活性反射性增高之故。与此同理，在整体中
Thin-Layer Chromatographic Analysis of Human CYP3A-Catalyzed Testosterone 6-Hydroxylation
used drugs are substrates for CYP3A, including erythromycin (10 ), infedipine (11 ) and midazolam (12 ). Immunoinhibition experiments with CYP3A subfamily-specific antibodies have established several microsomal enzyme activities, including nifedipine
技术资料暂无技术资料 索取技术资料
